BILL ANALYSIS



S.C.R. 56
By: Zaffirini/Moncrief (Berlanga)
05-04-95
Committee Report (Unamended)


BACKGROUND

In its report to the 74th Legislature, the Senate Health and Human
Services Committee recommended that the current Vendor Drug
Program, with additional cost containment measures to make the
program even more efficient, be retained in the proposed Medicaid
managed care system. Recent evaluations have concluded that the
program has done a very good job in implementing a variety of
prescription drug benefit management techniques. 

PURPOSE

S.C.R. 56 directs the State Medicaid Office, in implementing
Medicaid managed care, to continue to administer the prescription
drug benefit under the state Vendor Drug Program, and to accelerate
the implementation of computer-based rebate monitoring and
prospective drug utilization review as effective revenue
enhancement and cost containment measures.

SUMMARY OF COMMITTEE ACTION

S.C.R. 56 was considered by the Public Health Committee in a formal
meeting on May 3, 1995. The resolution was reported favorably
without amendement, with the recommendation that it do pass and be
printed, by a record vote of 7 AYES, 0 NAYS, 0 PNV, and 2 ABSENT.